CBDコンシューマーヘルスのグローバル市場2023-2030:医療用OTC製品、栄養補助食品

【英語タイトル】CBD Consumer Health Market Size, Share & Trends Analysis Report By Product (Medical OTC Products, Nutraceuticals), By Distribution Channels (Retail Pharmacies, Retail Stores, Online), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23NVB061)・商品コード:GRV23NVB061
・発行会社(調査会社):Grand View Research
・発行日:2023年10月4日
・ページ数:183
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

CBDコンシューマーヘルス市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のCBDコンシューマーヘルス市場規模は2030年までに611億7000万米ドルに達すると予測されています。2023年から2030年までの年平均成長率は18.1%と予測されています。カンナビジオール(CBD)の健康上の利点に関する意識の高まりと、これらの製品を合法化する国の数の増加により、消費者の健康製品としてのカンナビジオール(CBD)の採用が増加していることが、成長を促進する主な要因です。さらに、カンナビジオール製品に対する買い手の認識や態度の変化は、収益の成長を強化する重要な要因です。

製品タイプに基づくと、栄養補助食品は2019年に62.4%の収益シェアで市場を支配しました。カンナビジオールに関する認知度の上昇、栄養補助食品における化学ベースの成分からオーガニック成分へのユーザーの嗜好の変化、麻由来のカンナビジオールに対する政府の有利なイニシアチブは、成長を促進する主な要因です。この分野は、健康とウェルネス、スポーツ栄養、体重管理、その他の分野におけるCBDベースの栄養補助食品の消費の増加により、予測期間中に最も速いCAGRを目撃すると予想されています。

流通チャネルに基づくと、2019年には小売薬局がカンナビジオール消費者健康市場を支配しました。小売薬局経由で製品を販売する企業の増加が、このセグメントの成長を促進しています。しかし、オンラインストアセグメントは、予測期間中に最も速い成長を目撃すると予想されています。これは、電子商取引の浸透の増加、CBD入り製品に対する需要の高まり、CBDをオンラインで購入する消費者の嗜好、新興市場におけるこれらの製品の容易な入手が原因であると考えられます。

2019年の市場は北米が59.8%の収益シェアを占めました。消費者の間でCBDの医療効果に対する認識が高まっていることから、同地域ではオンライン販売や小売販売の売上が拡大しています。一方、欧州は、消費の増加、認知度の向上、CBD製品に関する前向きな姿勢、同地域の主要企業による戦略的投資などにより、最も急成長する地域となる見込みです。

CBDコンシューマーヘルス市場レポートハイライト

- 栄養補助食品は2022年の売上高シェア60%で市場を独占、これは栄養補助食品における化学ベースの成分からオーガニックやハーブ成分への消費者の嗜好の変化に起因します。

- 電子商取引の普及とオンラインで製品を提供するプレイヤーの増加により、オンラインストアが予測期間中に最も急成長する流通チャネルセグメントになると予想されます。

- 北米がカンナビジオール消費者健康製品のCBDコンシューマーヘルス市場を支配し、2022年の収益シェアは約70%でした。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. CBDコンシューマーヘルスの市場変数・傾向・範囲
第4章. CBDコンシューマーヘルスの世界市場:製品種類別予測・傾向分析
第5章. CBDコンシューマーヘルスの世界市場:流通チャネル別予測・傾向分析
第6章. CBDコンシューマーヘルスの世界市場:地域別予測・傾向分析
第7章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product Type
1.1.2. Distribution channel
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Distribution channel outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Cannabidiol (CBD) Consumer Health Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Cannabidiol (CBD) Consumer Health Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Cannabidiol (CBD) Consumer Health: Product Type Estimates & Trend Analysis
4.1. Cannabidiol (CBD) Consumer Health Market: Key Takeaways
4.2. Cannabidiol (CBD) Consumer Health Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Medical OTC Products
4.3.1. Medical OTC products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. CBD Analgesic Products
4.3.2.1. CBD analgesic products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. CBD Dermatology Products
4.3.3.1. CBD dermatology products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. CBD Mental Health Products
4.3.4.1. CBD mental health products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. CBD Sleeping Aids Products
4.3.5.1. CBD sleeping aids products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6. Other OTC Products
4.3.6.1. Other OTC products market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Nutraceuticals
4.4.1. Nutraceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. CBD Vitamins and Dietary Supplements (VDS)
4.4.2.1. CBD vitamins and dietary supplements (VDS) market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. CBD Sports Nutrition
4.4.3.1. CBD sports nutrition market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. CBD Weight Management and Wellbeing
4.4.4.1. CBD weight management and wellbeing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cannabidiol (CBD) Consumer Health: Distribution Channel Estimates & Trend Analysis
5.1. Cannabidiol (CBD) Consumer Health Market: Key Takeaways
5.2. Cannabidiol (CBD) Consumer Health Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Retail Pharmacies
5.3.1. Retail pharmacies market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Online
5.4.1. Online market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Retail Stores
5.5.1. Retail stores market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cannabidiol (CBD) Consumer Health Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Cannabidiol (CBD) Consumer Health Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Elixinol Global Limited
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. ENDOCA
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. NuLeaf Naturals LLC
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Kazmira
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Charlotte’s Web
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Joy Organics
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Lord Jones
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Medical Marijuana Inc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. CV Sciences Inc
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Isodiol International Inc
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 3 North America cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 4 North America cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 6 U.S. cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Canada cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 8 Canada cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 9 Europe cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 10 Europe cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 Europe cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
Table 12 Germany cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 13 Germany cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 14 UK cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 15 UK cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 France cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 17 France cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 18 Italy cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 19 Italy cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Spain cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 21 Spain cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 Sweden cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 23 Sweden cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 Norway cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 25 Norway cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 26 Denmark cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 27 Denmark cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 28 Asia Pacific cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 30 Asia Pacific cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
Table 31 China cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 32 China cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 33 Japan cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 34 Japan cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 35 India cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 36 India cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 37 Australia cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 38 Australia cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 39 Thailand cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 40 Thailand cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 41 South Korea cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 42 South Korea cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 43 Latin America cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 44 Latin America cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 45 Latin America cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 47 Brazil cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 48 Mexico cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 49 Mexico cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 50 Argentina cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 51 Argentina cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa cannabidiol (CBD) consumer health market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 56 South Africa cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 59 UAE cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 60 UAE cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)
Table 61 Kuwait cannabidiol (CBD) consumer health market, by product type, 2018 - 2030 (USD Million)
Table 62 Kuwait cannabidiol (CBD) consumer health market, by distribution channel, 2018 - 2030 (USD Million)

★調査レポート[CBDコンシューマーヘルスのグローバル市場2023-2030:医療用OTC製品、栄養補助食品] (コード:GRV23NVB061)販売に関する免責事項を必ずご確認ください。
★調査レポート[CBDコンシューマーヘルスのグローバル市場2023-2030:医療用OTC製品、栄養補助食品]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆